Targeting of the checkpoints of immune cell activation, such as cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1), have been shown to be effective means of activating anti-tumour immune responses (8). Here, CTLA4 is linked to neoplasm.